UK markets closed

Protagenic Therapeutics, Inc. (PTIX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2499-0.1201 (-8.77%)
As of 01:48PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
1,478
3,320
1,589
1,137
699.797
Selling general and administrative
2,285
1,207
1,969
3,004
1,852
Total operating expenses
3,763
4,527
3,558
4,140
2,552
Operating income or loss
-3,763
-4,527
-3,558
-4,140
-2,552
Interest expense
164.819
107.682
137.456
496.912
246.178
Total other income/expenses net
-42.472
-630.317
-46.051
81.184
248.552
Income before tax
-3,845
-5,000
-3,556
-4,523
-2,549
Income tax expense
0
0
0
0
0
Income from continuing operations
-3,845
-5,000
-3,556
-4,523
-2,549
Net income
-3,845
-5,000
-3,556
-4,523
-2,549
Net income available to common shareholders
-3,845
-5,000
-3,556
-4,523
-2,549
Basic EPS
-0.91
-1.15
-0.82
-1.24
-1.00
Diluted EPS
-0.91
-1.15
-0.82
-1.24
-1.00
Basic average shares
4,326
4,345
4,318
3,685
2,585
Diluted average shares
4,326
4,345
4,318
3,685
2,585